The MEMORY biobank focuses on research into biomarkers for memory impairment and dementia and their validation in clinical cohorts. The population consists of patients with dementia syndrome, mild cognitive impairment (MCI) or subjective cognitive impairment (SCD). The biobank contains clinical data and biomaterial (DNA, serum and EDTA plasma).
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Financial regulation for sub-biobanks15 September 2020
Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.read more